Antibiotic and antifungal use in paediatric departments at three academic hospitals in South Africa

Show simple item record

dc.contributor.author Moore, David P.
dc.contributor.author Chetty, Terusha
dc.contributor.author Pillay, Ashendri
dc.contributor.author Karsas, Maria
dc.contributor.author Cloete, Jeane
dc.contributor.author Balakrishna, Yusentha
dc.contributor.author Reddy, Tarylee
dc.contributor.author Archary, Moherndran
dc.contributor.author Van Kwawegen, Alison
dc.contributor.author Thomas, Reenu
dc.contributor.author Nakwa, Firdose L.
dc.contributor.author Waggie, Zainab
dc.contributor.author Magrath, Stephanie
dc.contributor.author Goga, Ameena Ebrahim
dc.contributor.author Jeena, Prakash
dc.date.accessioned 2024-05-28T12:23:06Z
dc.date.available 2024-05-28T12:23:06Z
dc.date.issued 2024-03
dc.description.abstract OBJECTIVES : South Africa implemented a National Strategic Framework to optimise antimicrobial stewardship in 2014; however, there is limited data on how this has affected prescribing, especially to children treated in academic centres. METHODS : We conducted a point prevalence survey using the World Health Organization (WHO) methodology to evaluate antibiotic and antifungal prescribing practices in paediatric departments at three academic hospitals in South Africa. RESULTS : We recorded 1946 antimicrobial prescriptions in 1191 children, with 55.2% and 39.2% of the antibiotics classified as WHO AWaRe Access and Watch drugs, respectively. There were significant differences in prescription of Reserve antibiotics and antifungals between institutions. Receipt of WHO Watch and Reserve antibiotics was independently associated with infancy (<12 months) and adolescents (13-17 years) (adjusted relative risk [aRR]: 2.09-9.95); prolonged hospitalisation (aRR: 3.29-30.08); rapidly or ultimately fatal illness (aRR: 1.94 to 5.52); and blood transfusion (aRR: 3.28-5.70). Antifungal prescribing was associated with treatment of hospital-associated infection (aRR: 2.90), medical prophylaxis (aRR: 3.30), and treatment in intensive care units (aRR: 2.15-2.27). CONCLUSIONS : Guidance on optimisation of infection prevention and control practice and strengthening of antimicrobial stewardship would impact positively on the care of sick children in our setting. en_US
dc.description.department Paediatrics and Child Health en_US
dc.description.librarian hj2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship UNICEF. en_US
dc.description.uri http://www.elsevier.com/locate/ijregi en_US
dc.identifier.citation Moore, D.P., Chetty, T., Pillay, A. et al. 2024, 'Antibiotic and antifungal use in paediatric departments at three academic hospitals in South Africa', IJID Regions, vol. 10, pp. 151-158, doi : 10.1016/j.ijregi.2023.12.004. en_US
dc.identifier.issn 2772-7076
dc.identifier.other 10.1016/j.ijregi.2023.12.004
dc.identifier.uri http://hdl.handle.net/2263/96275
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.rights © 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license. en_US
dc.subject SDG-03: Good health and well-being en_US
dc.subject AWaRe classification en_US
dc.subject Antimicrobial prescribing audit en_US
dc.subject Hospitalised children en_US
dc.subject Africa en_US
dc.title Antibiotic and antifungal use in paediatric departments at three academic hospitals in South Africa en_US
dc.type Postprint Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record